Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.

• Authors: P Chevallier, L Fornecker, B Lioure, M C Béné, A Pigneux, C Recher, B Witz, N Fegueux, C-E Bulabois, S Daliphard, D Bouscary, N Vey, M Delain, J-O Bay, P Turlure, M Bernard, C Himberlin, I Luquet, N Ifrah, J-L Harousseau, GOELAMS
• Journal: Leukemia (Leukemia) Vol. 24 Issue 7 Pg. 1380-5 (Jul 2010) ISSN: 1476-5551 [Electronic] England
• PMID: 20508614 (Publication Type: Clinical Trial, Phase III, Comparative Study, Letter, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Idarubicin
• Daunorubicin

Topics

• Adolescent
• Adult
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Cohort Studies
• Combined Modality Therapy
• Daunorubicin (administration & dosage)
• Feasibility Studies
• Female
• Humans
• Idarubicin (administration & dosage)
• Leukemia, Myeloid, Acute (pathology, therapy)
• Male
• Middle Aged
• Peripheral Blood Stem Cell Transplantation
• Prospective Studies
• Remission Induction
• Survival Rate
• Transplantation, Autologous
• Treatment Outcome
• Young Adult